At a glance

  • Normalize quotes against an identified finished product.
  • Set schedule gates for formula, samples, packaging, and artwork.
  • Keep batch review responsibilities distinct from sample approval.

Make the quotation describe the approved product

Request a quote identifying the tablet formula revision, ingredient grades, shape, finishing, serving concept, pack count, and retail components. Separate any pending development work from recurring supply. Ask what quantity assumptions and component commitments sit behind the minimum order. A stated minimum is more useful when the buyer understands which part of the project determines it.

Include testing, documentation, packaging setup, and delivery scope in the comparison. If two quotes differ, resolve the product definitions before comparing unit prices. Keep the commercial record linked to the accepted sample and technical specification. This helps prevent a quotation for a preliminary design from becoming the purchase basis for a revised tablet.

Build the schedule around decision gates

Ask the supplier to identify dependencies for materials, tooling, sample review, artwork, production, testing, and shipment. Record the approvals the buyer must provide and the dates each party is using for planning. Avoid treating an estimated manufacturing interval as the complete launch schedule when component selection or final development questions remain open.

Use explicit gates such as approval of the formula, sample, pack, and final print file. Ask how a revision affects later commitments. If the project has a required arrival date, discuss the assumptions behind it with the responsible logistics and production contacts. Preserve estimates as estimates until the relevant commitments and review steps are actually confirmed.

Align US artwork with the formulation record

FDA’s supplement labeling guide describes serving and nutrient declarations. Have the qualified reviewer check the actual label against the approved tablet and intended directions. Keep tablets per serving, servings per package, ingredient targets, full ingredient list, and retail count in separate fields. The design team should work from the accepted data rather than from an early marketing brief.

Review the print file using the actual package dimensions and the current product revision. Identify who approves the technical content and who approves the visual design. If formula, count, or packaging changes after review, return the affected information to the responsible reviewer. A graphic proof is useful only when it contains the correct approved product data.

Clarify the batch decision and documents

FDA dietary supplement CGMP guidance addresses manufacturing records and quality review. Agree on the documents the buyer will receive, how they identify the supplied lot, and who reviews them. Discuss relevant test reports, the supplier’s release status, packaging checks, and the connection between the shipped batch and the approved specification.

Keep sample acceptance separate from the decision concerning a particular supplied batch. Ask how deviations, substitutions, or unexpected observations will be communicated and assessed. A complete project file should let the buyer identify what was produced and what evidence was reviewed. It should not rely on a sample photograph or an unchanged product name as the whole basis for acceptance.

Maintain one controlled handoff package

Compile the accepted quotation, formula reference, tablet specification, packaging components, artwork version, review responsibilities, and document expectations. Include open questions and agreed follow-up dates. Use clear revision identifiers across the file so purchasing, design, and quality reviewers can recognize the same product definition without interpreting different versions of a conversational brief.

For repeat orders, review changes to materials, tooling, components, print files, and delivery assumptions before issuing the new purchase. Ask the relevant team to assess the impact and update the authoritative record. This keeps the launch process manageable and gives future buyers a concrete basis for deciding whether the order remains within the accepted tablet project.

Common questions

Can a supplier’s production estimate serve as the full launch timeline?

Review all dependencies, including development, buyer approvals, components, testing, and logistics, before treating it as a launch commitment.

Does approving the label also approve the supplied batch?

No. Artwork approval and the review of a specific batch have different scopes and should have clearly assigned responsibilities.

Sources & further reading

These sources support the general technical context. They do not verify the credentials or capacity of a specific factory. This guide is for manufacturing planning; it does not provide medical advice or product efficacy claims.